Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers75
Expression, Prognostic Value, and Immune Infiltration of MTHFD Family in Bladder Cancer39
Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway38
Identification of ATM Mutation as a Potential Prognostic Biomarker for Immune Checkpoint Inhibitors Therapy27
A Review on Patient-derived 3D Micro Cancer Approach for Drug Screen in Personalized Cancer Medicine25
Efficacy and Safety of Immunotherapy Combined with Anlotinib as FirstLine Treatment in Older NSCLC Patients with PD-L1 Expression<50%24
Spinal KCC2 Mediates the Modulation Effect of HDAC2 on Bone Cancer Pain in Rats24
The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer24
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice22
A Pilot Study of Anlotinib as a Combination Treatment in Advanced Nasopharyngeal Carcinoma21
Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer21
Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma19
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy18
Silencing HEATR1 Rescues Cisplatin Resistance of Non-small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis15
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway15
0.064263820648193